Scores by kind of claim
Each kind of claim is scored on its own, out of 100: the share that held up, with the range it likely falls in. Fewer resolved claims give a wider range.
-
Factual claims
Statements about the present or the past, checked against the record: did they hold up?
83 77 88 -
Predictions
Statements about events outside the person's control, checked once they fell due: did they come true?
69 49 87 -
Promises
Commitments to the person's or organisation's own future action, with something to deliver: was it delivered?
69 49 87
All types combined: 81 (likely 76 to 86, high confidence), from 87 claims: 77 factual claims, 5 predictions, 5 promises. It mixes kinds of claim in different proportions for different people, so compare people kind by kind.
Sam Altman's claims
41 claims
“Psilocybin-assisted therapy company goes public.”
Sam Altman, posting on X 22 September 2020 Post by @sama on X, 2020-09-22 (X)
A psilocybin-assisted therapy company has gone public (as of 2020-09-22).
Resolved true The record shows it happened or was so.
What would count as true or false
Judged as of 2020-09-22. True: on or before that date, a company whose core business is developing psilocybin-assisted therapy completed an IPO or a listing of its shares on a public stock exchange; a listing in the days just before the statement fits the claim. Mostly true: the listing took place, with a minor slip in a detail, such as psilocybin therapy being the company's lead programme rather than its only business. Mostly false: the only listed companies were psychedelic firms not focused on psilocybin-assisted therapy, or an IPO had only been filed or priced and not completed by that date. False: no psilocybin-assisted therapy company had gone public by 2020-09-22.
Evidence
- COMPASS Pathways announces closing of initial public offering of American Depositary Shares and full exercise of underwriters’ option to purchase additional American Depositary Shares COMPASS Pathways plc (company press release, via its investor relations site) · 22 September 2020
“The ADSs began trading on the Nasdaq Global Select Market on September 18, 2020 under the ticker symbol “CMPS.””
- COMPASS Pathways announces closing of initial public offering of American Depositary Shares and full exercise of underwriters’ option to purchase additional American Depositary Shares COMPASS Pathways plc (company press release, via its investor relations site) · 22 September 2020
“We are pioneering the development of a new model of psilocybin therapy, in which our proprietary formulation of synthetic psilocybin, COMP360, is administered in conjunction with psychological support.”
- Statement: MAPS Congratulates Compass Pathways on Initial Public Offering to Advance Psychedelic Therapies Multidisciplinary Association for Psychedelic Studies (MAPS) · 23 September 2020
“today congratulated Compass Pathways on their initial public offering last Friday which has resulted a doubling of their stock price and $1.3 billion valuation.”
- 2020's top 5 advancements in psychedelics Mugglehead · 30 December 2020
“In September, Compass Pathways (Nasdaq: CMPS) debuted on Nasdaq, making it the first psychedelics firm to list on a major U.S. stock exchange.”
Reasoning
COMPASS Pathways announced on 2020-09-22 that its IPO had closed. It also said its ADSs began trading on the Nasdaq Global Select Market on September 18, 2020 (E1). The same release describes its core business as developing psilocybin therapy built around COMP360, its synthetic psilocybin formulation (E2). Independent sources confirm the IPO and Nasdaq debut (E3, E4). This is a completed listing by a psilocybin-therapy company in the days just before the claim date, which meets the criteria for true.
Cite this claim
Sam Altman, “A psilocybin-assisted therapy company has gone public (as of 2020-09-22).” (said 22 September 2020). Verdict: resolved true. Reliability API, claim c_3d30201a3bd7, method 0.1.0+c876030c. https://epistacklabs.com/claims/c_3d30201a3bd7
Claims without a verdict
Is a verdict here wrong, or do you speak for Sam Altman? Reply on the claim's own page, with the form at its foot (how replies work). Verdicts are made automatically; how verdicts and scores are made.